Skip to main content
SpringerLink
Log in

Tocilizumab

Infection and worsening of pre-existing COVID-19 symptoms following off-label treatment: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Wang Y, et al. Does tocilizumab have a magical therapeutic effect on COVID-19 patients without obvious adverse reactions?. Proceedings of the National Academy of Sciences of the United States of America 117: 30896-30897, No. 49, 8 Dec 2020. Available from: URL: http://doi.org/10.1073/pnas.2009961117

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tocilizumab. Reactions Weekly 1841, 227 (2021). https://doi.org/10.1007/s40278-021-90729-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-90729-9

Search

Navigation